Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
about
Blood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseNovel insights in the management of sickle cell disease in childhoodHematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerationsA biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical careEditorial brain malformation surveillance in the Zika eraGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.How I manage cerebral vasculopathy in children with sickle cell disease.Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients.Sickle cell disease: a neglected chronic disease of increasing global health importanceHealth-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.Predictors of neurological outcomes after successful extracorporeal cardiopulmonary resuscitation.Principles of cerebral hemodynamics when intracranial pressure is raised: lessons from the peripheral circulation.How I treat and manage strokes in sickle cell disease.Examination of Reticulocytosis among Chronically Transfused Children with Sickle Cell Anemia.Mortal quintet of sickle cell diseases.Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.Cerebral hemodynamic assessment and neuroimaging across the lifespan in sickle cell disease.Interventions for preventing silent cerebral infarcts in people with sickle cell disease.Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.Deoxygenation Reduces Sickle Cell Blood Flow at Arterial Oxygen TensionSociety of Vascular and Interventional Neurology (SVIN) Stroke Interventional Laboratory Consensus (SILC) Criteria: A 7M Management Approach to Developing a Stroke Interventional Laboratory in the Era of Stroke Thrombectomy for Large Vessel OcclusiomTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Sickle Cell Disease with Cyanotic Congenital Heart Disease: Long-Term Outcomes in 5 Children.Maintaining High Level of Care at Satellite Sickle Cell Clinics.A pilot study of parent education intervention improves early childhood development among toddlers with sickle cell diseaseHow we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.The trials and hopes for drug development in sickle cell disease.Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease.Sickle Cell Disease and Stroke: Diagnosis and Management.Headache and Facial Pain in Sickle Cell Disease.Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.Pediatric sickle cell disease: past successes and future challenges.Cognitive deficits are associated with unemployment in adults with sickle cell anemia.Clinically-oriented proteomic investigation of sickle cell disease: Opportunities and challenges.Prevalence of Developmental Delay and Contributing Factors Among Children With Sickle Cell Disease.Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.Cranial epidural hematomas: A case series and literature review of this rare complication associated with sickle cell disease.Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature.
P2860
Q24202463-EEA1CE8E-7A78-4028-83BD-6DC583145B97Q26767015-9045A8CB-3365-452F-876F-6D6E1C668938Q26800236-1DECCEA4-27E6-48D6-BB21-5B6DA314461EQ27024148-96BAE2FD-65BC-48A4-B30C-A36311DB4A19Q27927969-C1FDADC9-34A7-418B-9A07-30AC79A6E79FQ30276550-EAD3D7F9-9CD1-4D21-A19F-DC1876459CD4Q30945117-24C1D676-690B-4B62-869F-F49D552C48EFQ33679897-B8D59C61-9B2E-4D1F-9F12-D774D84833A5Q34852524-E69604C8-8651-4B38-B64C-A24169C4100BQ35007607-81FA86D4-CA9B-4BD1-9B1C-7DC412C892E9Q35174249-31578F0C-1695-4C90-8892-5B3EA901C542Q35694265-AAB02473-12EB-426C-8502-586315614E80Q35743944-51CA0E45-1197-4B6A-B8F0-08295C8626FEQ35999807-6F02D464-B559-4762-ABF2-7054DA5A0C6AQ36046731-6EF5E353-4B2F-476F-99C5-5E4316A00E9AQ36251052-F123AE60-FE3C-448D-9283-C0F1AACD7347Q36349336-9D0FD961-4D12-448B-9859-577E5440FFC2Q36370980-69AE99AF-5D9A-4DAA-A37C-83A5296313ACQ37033939-D83F9D3E-08C4-4745-8171-1A19B0855917Q37034780-A27FF9C6-254A-48FA-9073-28348C60C73FQ37069202-1576C6E2-1A25-4CC2-A4C4-D7533DAA5CA5Q37123996-07501500-6583-43FE-ACC3-537471BE92CBQ37251490-276F15C3-11B4-4DCF-8DD3-DF465C49CB31Q37527752-465547C5-B9CF-49AF-89D7-232A68B12228Q37607927-80942881-14AB-4E30-9B78-A30F2F12C781Q37691154-9D3327E4-E9F7-444C-A9F6-058AF1AEE84EQ38476241-3DBD7879-E243-4157-8D49-3C0841B6EBAFQ38540335-BCC384ED-BB7E-445B-A207-2CFEA331530EQ38627797-48F4D4FE-B4AC-4EE7-8E5B-51ED7B35EA0AQ38641106-7E94505B-08DC-4009-9717-C3F7F5A847F3Q38732049-177D801D-40C9-4945-A0A0-7E9136B0F762Q38734763-7618656F-B04D-48DB-BB68-7D6164336C68Q38788354-CB833CEE-79B9-4700-8C34-50938FC7A6BAQ38814652-5D1908FF-6720-46D3-B624-0D312E12EDA0Q38831964-C77B9DE4-DD31-4A3E-8F60-5391A8B60A58Q38837694-F699747A-13A3-41E2-9F2D-B2A1D25B7421Q38942105-78371885-FD77-4FBF-BF6A-8A446D94CE5FQ38949082-C38F096E-32E2-479C-AE55-75176431000FQ38952127-51E3FE74-01CF-49AB-AFEB-52B1C86281A9Q38985177-B53C023F-C0DA-4018-9585-F832752F0E54
P2860
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
@ast
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
@en
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
@nl
type
label
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
@ast
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
@en
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
@nl
prefLabel
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
@ast
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
@en
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
@nl
P2093
P2860
P50
P356
P1476
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
@en
P2093
Alexis A Thompson
Annie Kamdem
Beng R Fuh
Brian Berman
Corina E Gonzalez
Deborah Hirtz
Desiree A White
Emily R Meier
Gerald M Woods
Gladstone Airewele
P2860
P304
P356
10.1056/NEJMOA1401731
P407
P577
2014-08-01T00:00:00Z